• Mashup Score: 11

    Hyperglycaemia in people with and without diabetes admitted to the hospital is associated with a substantial increase in morbidity, mortality, and health-care costs. Professional societies have recommended insulin therapy as the cornerstone of inpatient pharmacological management. Intravenous insulin therapy is the treatment of choice in the critical care setting. In non-intensive care settings,…

    Tweet Tweets with this article
    • In our #MostRead: Management of #diabetes and #hyperglycaemia in the #hospital https://t.co/qlfviBRfJa #T1D #T2D #insulin #COVID19 #FREE to read https://t.co/6KrEGD7KoK

  • Mashup Score: 1

    In the post-acute phase, we report increased risks and 12-month burdens of incident diabetes and antihyperglycaemic use in people with COVID-19 compared with a contemporary control group of people who were enrolled during the same period and had not contracted SARS-CoV-2, and a historical control group from a pre-pandemic era. Post-acute COVID-19 care should involve identification and management…

    Tweet Tweets with this article
    • #MostRead—Risks and burdens of incident #diabetes in long #COVID: a cohort study https://t.co/xWdiowORxO #LongCovid #COVID19 #FREE to read